乳房切除术后立即进行基于植入物的乳房重建与辅助治疗的延迟无关
Lilian Paz1,2, Jorge Biazús1
1Postgraduate Program in Health Sciences: Gynecology and Obstetrics, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
乳房切除术后立即进行植入式乳房重建 (IBR) 不会延迟辅助治疗的开始. 这一发现支持将IBR整合到乳腺癌治疗中,而不会影响及时的护理,特别是对于黑人女性.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 乳腺癌治疗方法 乳腺癌治疗方法
背景情况:
- 立即的乳房重建 (IBR) 可以提高乳房切除术后的生活质量.
- 由于IBR并发症,人们对潜在的辅助疗法延迟存在担忧,这会影响瘤学结果.
研究的目的:
- 评估基于植入物的即时乳房重建对辅助治疗开始时间的影响.
- 评估IBR是否影响乳腺切除术后化疗或放射治疗的及时性.
主要方法:
- 对930名乳腺癌I-III期进行乳房切除的女性进行了回顾性队列研究 (2018-2022).
- 分层分组:乳腺切除术与IBR (n=200) 与单独的乳腺切除术 (n=730).
- 主要结局:从最终手术到第一个辅助治疗的时间;延迟定义为>12周.
主要成果:
- 接受IBR治疗的女性比未接受IBR治疗的女性 (12.0周) 提前显著 (11.0周) 开始辅助治疗.
- 较少的IBR患者经历了治疗延迟 (33.3%与47.4%相比).
- 多变量分析表明IBR不是延迟的重要预测因素;晚期和流行病时间是关键因素.
结论:
- 在这个群体中,即时的基于植入物的乳房重建不会延迟辅助治疗的开始,主要是黑人女性.
- IBR可以安全地纳入乳腺癌治疗计划,确保及时获得护理.
- 晚期疾病阶段和医疗保健系统因素仍然是治疗延迟的关键因素.
更多相关视频
05:05Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
06:42Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025
相关概念视频
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
05:05Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
06:42Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
04:13An Adjuvant Therapy in a Mouse Model with an Incompletely Resected Subcutaneous Tumor
08:16X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models
08:153D Planning and Printing of Patient Specific Implants for Reconstruction of Bony Defects
